Get started
LAURUS LABS LIMITEDLAURUS LABS LIMITEDLAURUS LABS LIMITED

LAURUS LABS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

LAURUSLABS chart


Full chart

LAURUSLABS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪325.12 B‬ INR
Dividend yield (indicated)
0.20%
Price to earnings Ratio (TTM)
90.95
Basic EPS (TTM)
6.65 INR
Net income (FY)
‪3.58 B‬ INR
Revenue (FY)
‪55.54 B‬ INR
Shares float
‪357.40 M‬
Beta (1Y)
1.18

Employees


Employees (FY)
‪7.04 K‬
Change (1Y)
‪−4.59 K‬ −39.45%
Revenue / Employee (1Y)
‪7.89 M‬ INR
Net income / Employee (1Y)
‪508.83 K‬ INR

About LAURUS LABS LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Satyanarayana Chava
Website
lauruslabs.com
Headquarters
Hyderabad
Founded
2005
ISIN
INE947Q01028
FIGI
BBG00FFGJFX4
Laurus Labs Ltd. develops and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The company was founded by Dr. Satyanarayana Chava on September 19, 2005 and is headquartered in Hyderabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LAURUSLABS news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as LAURUSLABS.

Frequently Asked Questions


The current price of LAURUSLABS is 602.90 INR — it has decreased by −0.20% in the past 24 hours. Watch LAURUS LABS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange LAURUS LABS LIMITED stocks are traded under the ticker LAURUSLABS.
LAURUSLABS stock has risen by 3.32% compared to the previous week, the month change is a −3.54% fall, over the last year LAURUS LABS LIMITED has showed a 37.29% increase.
We've gathered analysts' opinions on LAURUS LABS LIMITED future price: according to them, LAURUSLABS price has a max estimate of 750.00 INR and a min estimate of 475.00 INR. Watch LAURUSLABS chart and read a more detailed LAURUS LABS LIMITED stock forecast: see what analysts think of LAURUS LABS LIMITED and suggest that you do with its stocks.
LAURUSLABS reached its all-time high on Aug 12, 2021 with the price of 723.55 INR, and its all-time low was 59.60 INR and was reached on Aug 7, 2019. View more price dynamics on LAURUSLABS chart.
See other stocks reaching their highest and lowest prices.
LAURUSLABS stock is 1.78% volatile and has beta coefficient of 1.18. Track LAURUS LABS LIMITED stock price on the chart and check out the list of the most volatile stocks — is LAURUS LABS LIMITED there?
Today LAURUS LABS LIMITED has the market capitalization of ‪325.12 B‬, it has decreased by −2.43% over the last week.
Yes, you can track LAURUS LABS LIMITED financials in yearly and quarterly reports right on TradingView.
LAURUS LABS LIMITED is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
LAURUSLABS earnings for the last quarter are 4.30 INR per share, whereas the estimation was 3.29 INR resulting in a 30.80% surprise. The estimated earnings for the next quarter are 2.03 INR per share. See more details about LAURUS LABS LIMITED earnings.
LAURUS LABS LIMITED revenue for the last quarter amounts to ‪17.20 B‬ INR, despite the estimated figure of ‪16.21 B‬ INR. In the next quarter, revenue is expected to reach ‪14.89 B‬ INR.
LAURUSLABS net income for the last quarter is ‪2.34 B‬ INR, while the quarter before that showed ‪923.00 M‬ INR of net income which accounts for 153.16% change. Track more LAURUS LABS LIMITED financial stats to get the full picture.
As of May 18, 2025, the company has ‪7.04 K‬ employees. See our rating of the largest employees — is LAURUS LABS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LAURUS LABS LIMITED EBITDA is ‪10.55 B‬ INR, and current EBITDA margin is 19.00%. See more stats in LAURUS LABS LIMITED financial statements.
Like other stocks, LAURUSLABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LAURUS LABS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LAURUS LABS LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LAURUS LABS LIMITED stock shows the buy signal. See more of LAURUS LABS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.